Literature DB >> 26812624

Transplantation from a symptomatic carrier sister restores host defenses but does not prevent colitis in NEMO deficiency.

Christian Klemann1, Ulrich Pannicke2, Deborah J Morris-Rosendahl3, Katerina Vlantis4, Marta Rizzi5, Holm Uhlig6, Thomas Vraetz7, Carsten Speckmann1, Brigitte Strahm7, Manolis Pasparakis4, Klaus Schwarz8, Stephan Ehl1, Jan C Rohr9.   

Abstract

NF-κB essential modulator (NEMO) deficiency causes ectodermal dysplasia with immunodeficiency in males, while manifesting as incontinentia pigmenti in heterozygous females. We report a family with NEMO deficiency, in which a female carrier displayed skewed X-inactivation favoring the mutant NEMO allele associated with symptoms of Behçet's disease. Hematopoietic stem cell transplantation of an affected boy from this donor reconstituted an immune system with retained skewed X-inactivation. After transplantation no more severe infections occurred, indicating that an active wild-type NEMO allele in only 10% of immune cells restores host defense. Yet he developed inflammatory bowel disease (IBD). While gut infiltrating immune cells stained strongly for nuclear p65 indicating restored NEMO function, this was not the case in intestinal epithelial cells - in contrast to cells from conventional IBD patients. These results extend murine observations that epithelial NEMO-deficiency suffices to cause IBD. High anti-TNF doses controlled the intestinal inflammation and symptoms of Behçet's disease.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anti-TNF treatment; Behçet's disease; HSCT; IBD; IKBKG; NEMO deficiency; Skewed X-inactivation

Mesh:

Substances:

Year:  2016        PMID: 26812624      PMCID: PMC6101191          DOI: 10.1016/j.clim.2016.01.010

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  29 in total

Review 1.  Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity.

Authors:  M Karin; Y Ben-Neriah
Journal:  Annu Rev Immunol       Date:  2000       Impact factor: 28.527

2.  Skin lesion development in a mouse model of incontinentia pigmenti is triggered by NEMO deficiency in epidermal keratinocytes and requires TNF signaling.

Authors:  Arianna Nenci; Marion Huth; Alfred Funteh; Marc Schmidt-Supprian; Wilhelm Bloch; Daniel Metzger; Pierre Chambon; Klaus Rajewsky; Thomas Krieg; Ingo Haase; Manolis Pasparakis
Journal:  Hum Mol Genet       Date:  2006-01-06       Impact factor: 6.150

3.  Correction of immunodeficiency associated with NEMO mutation by umbilical cord blood transplantation using a reduced-intensity conditioning regimen.

Authors:  C Tono; Y Takahashi; K Terui; S Sasaki; T Kamio; S Tandai; T Sato; K Kudo; T Toki; N Tachibana; T Yoshioka; T Nakahata; T Morio; R Nishikomori; E Ito
Journal:  Bone Marrow Transplant       Date:  2007-04-09       Impact factor: 5.483

Review 4.  Crosstalk in NF-κB signaling pathways.

Authors:  Andrea Oeckinghaus; Matthew S Hayden; Sankar Ghosh
Journal:  Nat Immunol       Date:  2011-07-19       Impact factor: 25.606

5.  RIPK1 maintains epithelial homeostasis by inhibiting apoptosis and necroptosis.

Authors:  Marius Dannappel; Katerina Vlantis; Snehlata Kumari; Apostolos Polykratis; Chun Kim; Laurens Wachsmuth; Christina Eftychi; Juan Lin; Teresa Corona; Nicole Hermance; Matija Zelic; Petra Kirsch; Marijana Basic; Andre Bleich; Michelle Kelliher; Manolis Pasparakis
Journal:  Nature       Date:  2014-08-17       Impact factor: 49.962

6.  Osteopetrosis, lymphedema, anhidrotic ectodermal dysplasia, and immunodeficiency in a boy and incontinentia pigmenti in his mother.

Authors:  Sophie Dupuis-Girod; Nadège Corradini; Smail Hadj-Rabia; Jean-Christophe Fournet; Laurence Faivre; Françoise Le Deist; Philippe Durand; Rainer Döffinger; Asma Smahi; Alain Israel; Gilles Courtois; Nicole Brousse; Stéphane Blanche; Arnold Munnich; Alain Fischer; Jean-Laurent Casanova; Christine Bodemer
Journal:  Pediatrics       Date:  2002-06       Impact factor: 7.124

7.  Deficient natural killer cell cytotoxicity in patients with IKK-gamma/NEMO mutations.

Authors:  Jordan S Orange; Scott R Brodeur; Ashish Jain; Francisco A Bonilla; Lynda C Schneider; Roberto Kretschmer; Samuel Nurko; Wendy L Rasmussen; Julia R Köhler; Stephen E Gellis; Betsy M Ferguson; Jack L Strominger; Jonathan Zonana; Narayanaswamy Ramesh; Zuhair K Ballas; Raif S Geha
Journal:  J Clin Invest       Date:  2002-06       Impact factor: 14.808

8.  Hypomorphic nuclear factor-kappaB essential modulator mutation database and reconstitution system identifies phenotypic and immunologic diversity.

Authors:  Eric P Hanson; Linda Monaco-Shawver; Laura A Solt; Lisa A Madge; Pinaki P Banerjee; Michael J May; Jordan S Orange
Journal:  J Allergy Clin Immunol       Date:  2008-10-11       Impact factor: 10.793

Review 9.  Allogeneic hematopoietic stem cell transplantation for X-linked ectodermal dysplasia and immunodeficiency: case report and review of outcomes.

Authors:  Perdita Permaul; Anupama Narla; Jason L Hornick; Sung-Yun Pai
Journal:  Immunol Res       Date:  2009       Impact factor: 2.829

10.  Epithelial NEMO links innate immunity to chronic intestinal inflammation.

Authors:  Arianna Nenci; Christoph Becker; Andy Wullaert; Ralph Gareus; Geert van Loo; Silvio Danese; Marion Huth; Alexei Nikolaev; Clemens Neufert; Blair Madison; Deborah Gumucio; Markus F Neurath; Manolis Pasparakis
Journal:  Nature       Date:  2007-03-14       Impact factor: 49.962

View more
  10 in total

1.  Infliximab therapy for inflammatory colitis in an infant with NEMO deficiency.

Authors:  Hasibe Artac; Ayca Emsen; Hulya Ucaryilmaz; Halil Haldun Emiroglu; Vedat Uygun; Asbjørg Stray-Pedersen
Journal:  Immunol Res       Date:  2019-10       Impact factor: 2.829

Review 2.  Linking Genetic Diagnosis to Therapeutic Approach in Very Early Onset Inflammatory Bowel Disease: Pharmacologic Considerations.

Authors:  Anne E Levine; Hengqi B Zheng; David L Suskind
Journal:  Paediatr Drugs       Date:  2022-04-25       Impact factor: 3.022

3.  Low Density Granulocytes and Dysregulated Neutrophils Driving Autoinflammatory Manifestations in NEMO Deficiency.

Authors:  Naz Surucu Yilmaz; Sevgi Bilgic Eltan; Basak Kayaoglu; Safa Baris; Mayda Gursel; Busranur Geckin; Raul Jimenez Heredia; Asena Pinar Sefer; Ayca Kiykim; Ercan Nain; Nurhan Kasap; Omer Dogru; Ayse Deniz Yucelten; Leyla Cinel; Gulsun Karasu; Akif Yesilipek; Betul Sozeri; Goksu Gokberk Kaya; Ismail Cem Yilmaz; Ilayda Baydemir; Yagmur Aydin; Deniz Cansen Kahraman; Matthias Haimel; Kaan Boztug; Elif Karakoc-Aydiner; Ihsan Gursel; Ahmet Ozen
Journal:  J Clin Immunol       Date:  2022-01-14       Impact factor: 8.317

4.  Progressive B cell depletion in human MALT1 deficiency.

Authors:  Motoshi Sonoda; Masataka Ishimura; Katsuhide Eguchi; Yutaro Yada; Nina Lenhartová; Akira Shiraishi; Tamami Tanaka; Yasunari Sakai; Shouichi Ohga
Journal:  Clin Exp Immunol       Date:  2021-10-07       Impact factor: 4.330

5.  T Cell Impairment Is Predictive for a Severe Clinical Course in NEMO Deficiency.

Authors:  Stephanie Heller; Uwe Kölsch; Thomas Magg; Renate Krüger; Andrea Scheuern; Holm Schneider; Anna Eichinger; Volker Wahn; Nadine Unterwalder; Myriam Lorenz; Klaus Schwarz; Christian Meisel; Ansgar Schulz; Fabian Hauck; Horst von Bernuth
Journal:  J Clin Immunol       Date:  2020-01-21       Impact factor: 8.317

Review 6.  Primary Immunodeficiency Disease Mimicking Pediatric Bechet's Disease.

Authors:  Mayuka Shiraki; Saori Kadowaki; Tomonori Kadowaki; Norio Kawamoto; Hidenori Ohnishi
Journal:  Children (Basel)       Date:  2021-01-22

Review 7.  New Insights and Advances in Pathogenesis and Treatment of Very Early Onset Inflammatory Bowel Disease.

Authors:  Qi-Qi Li; Hui-Hong Zhang; Shi-Xue Dai
Journal:  Front Pediatr       Date:  2022-03-01       Impact factor: 3.418

8.  Genetically programmed alternative splicing of NEMO mediates an autoinflammatory disease phenotype.

Authors:  Younglang Lee; Alex W Wessel; Jiazhi Xu; Julia G Reinke; Eries Lee; Somin M Kim; Amy P Hsu; Jevgenia Zilberman-Rudenko; Sha Cao; Clinton Enos; Stephen R Brooks; Zuoming Deng; Bin Lin; Adriana A de Jesus; Daniel N Hupalo; Daniela Gp Piotto; Maria T Terreri; Victoria R Dimitriades; Clifton L Dalgard; Steven M Holland; Raphaela Goldbach-Mansky; Richard M Siegel; Eric P Hanson
Journal:  J Clin Invest       Date:  2022-03-15       Impact factor: 14.808

9.  Hematopoietic stem cell transplantation in 29 patients hemizygous for hypomorphic IKBKG/NEMO mutations.

Authors:  Charline Miot; Kohsuke Imai; Chihaya Imai; Anthony J Mancini; Zeynep Yesim Kucuk; Tokomki Kawai; Ryuta Nishikomori; Etsuro Ito; Isabelle Pellier; Sophie Dupuis Girod; Jeremie Rosain; Shinya Sasaki; Shanmuganathan Chandrakasan; Jana Pachlopnik Schmid; Tsubasa Okano; Estelle Colin; Alberto Olaya-Vargas; Marco Yamazaki-Nakashimada; Waseem Qasim; Sara Espinosa Padilla; Andrea Jones; Alfons Krol; Nyree Cole; Stephen Jolles; Jack Bleesing; Thomas Vraetz; Andrew R Gennery; Mario Abinun; Tayfun Güngör; Beatriz Costa-Carvalho; Antonio Condino-Neto; Paul Veys; Steven M Holland; Gulbu Uzel; Despina Moshous; Benedicte Neven; Stéphane Blanche; Stephan Ehl; Rainer Döffinger; Smita Y Patel; Anne Puel; Jacinta Bustamante; Erwin W Gelfand; Jean-Laurent Casanova; Jordan S Orange; Capucine Picard
Journal:  Blood       Date:  2017-07-05       Impact factor: 22.113

10.  Autoimmunity/inflammation in a monogenic primary immunodeficiency cohort.

Authors:  William Rae; Daniel Ward; Christopher J Mattocks; Yifang Gao; Reuben J Pengelly; Sanjay V Patel; Sarah Ennis; Saul N Faust; Anthony P Williams
Journal:  Clin Transl Immunology       Date:  2017-09-15
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.